Literature DB >> 2288877

Transforming growth factor beta 1 acts as an autocrine-negative growth regulator in colon enterocytic differentiation but not in goblet cell maturation.

M M Hafez1, D Infante, S Winawer, E Friedman.   

Abstract

Previous studies from this laboratory (Schroy, P., Rifkin, J., Coffey, R.J., Winawer, S., and Friedman, E. (Cancer Res., 50: 261-265, 1990; Schroy, P.C., Winawer, S., and Friedman, E. Cancer Lett., 48: 53-58, 1989) found that a 7-day treatment of the human colon carcinoma cell line HT29 with the differentiation agent hexamethylene bisacetamide (HMBA) induces both a 4-5-fold increase in transforming growth factor beta 1 (TGF beta 1) mRNA levels and reduced tumorigenicity in vivo. A series of 15 cloned lines with different commitments to differentiation has been isolated from 20-day HMBA-treated HT29 cells, maintained without HMBA, and utilized to study the role of TGF beta 1 in colon carcinoma differentiation. Two such lines, HD6 and HD8, differentiate to 97 and 76% mucus-secreting goblet cells, respectively, in columnar monolayers in postconfluent culture. Both HD6 and HD8 cells exhibit low TGF beta 1 mRNA levels, little different from the undifferentiated HT29 parental line, and exhibit no growth modulation in response to exogenous TGF beta 1. In contrast, two other lines, HD3 and HD4, differentiate to fluid-transporting enterocytic cells with functional brush borders and exhibit autocrine-negative growth response to TGF beta 1. Both lines express TGF beta 1 mRNA at levels 11-12-fold higher than the parental line and respond to exogenous TGF beta 1 by growth inhibition. HD3 cells secrete biologically active TGF beta 1 into conditioned media, which inhibited growth of a TGF beta 1-sensitive mink cell line. This inhibition was blocked by antisera to TGF beta 1, proving the specificity of the inhibition. A range of concentrations of this TGF beta 1 antiserum stimulated HD3 cell growth in a dose-dependent manner, further documenting the autocrine-negative response of the cells to TGF beta 1. Another cell line, HI1, was blocked in enterocytic differentiation. HI1 cells synthesized as much TGF beta 1 mRNA as HD3 and HD4 cells, yet they responded to exogenous TGF beta 1 with less growth inhibition, suggesting some impairment in their response to TGF beta 1. A third class of response to TGF beta 1 was exhibited by the HP1 cell line, which was resistant to HMBA-induced differentiation, remaining undifferentiated with a multilayered growth pattern. HP1 cells synthesized TGF beta 1 mRNA at levels over 20 times the parental level but were stimulated to divide by TGF beta 1, exhibiting autocrine-positive response to this growth factor.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2288877

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  13 in total

1.  GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.

Authors:  Narasimhaswamy S Belaguli; Muhammad Aftab; Mohammed Rigi; Mao Zhang; Daniel Albo; David H Berger
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Intestinal HT-29 cells with dysfunction of E-cadherin show increased pp60src activity and tyrosine phosphorylation of p120-catenin.

Authors:  A Skoudy; M D Llosas; A García de Herreros
Journal:  Biochem J       Date:  1996-07-01       Impact factor: 3.857

3.  Targeted deletion of Smad4 shows it is required for transforming growth factor beta and activin signaling in colorectal cancer cells.

Authors:  S Zhou; P Buckhaults; L Zawel; F Bunz; G Riggins; J L Dai; S E Kern; K W Kinzler; B Vogelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

4.  Adhesion of human enterotoxigenic Escherichia coli to human mucus secreting HT-29 cell subpopulations in culture.

Authors:  S Kerneis; M F Bernet; M H Coconnier; A L Servin
Journal:  Gut       Date:  1994-10       Impact factor: 23.059

5.  Potent cytodifferentiating agents related to hexamethylenebisacetamide.

Authors:  R Breslow; B Jursic; Z F Yan; E Friedman; L Leng; L Ngo; R A Rifkind; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

6.  Immunolocalization of a new intestinal antiproliferative factor in human intestinal epithelial cells.

Authors:  Christian Lavagna; Carine Strup; Agnes Rampal; Paul Hofman; Sylvie Bardon; Patrick Rampal; Jean-Claude Poirée
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 7.  Transforming growth factor-beta and prostate cancer.

Authors:  M S Steiner
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  The role of growth regulatory aberrations in progression of human colon carcinoma.

Authors:  G M Howell; L Sun; B L Ziober; S P Wu; M G Brattain
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

9.  Expression of TGF-beta during in vitro differentiation of hamster tracheal epithelial cells.

Authors:  R M Niles; N L Thompson; F Fenton
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-04       Impact factor: 2.416

10.  Dihydrofolate reductase gene amplification-associated shift of differentiation in methotrexate-adapted HT-29 cells.

Authors:  T Lesuffleur; A Barbat; C Luccioni; J Beaumatin; M Clair; A Kornowski; E Dussaulx; B Dutrillaux; A Zweibaum
Journal:  J Cell Biol       Date:  1991-12       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.